TrialOpen forum infectious diseases2026

Rapidly Expanded EBV-Specific T Cells for the Treatment of Refractory EBV Reactivation and EBV-Related Lymphoproliferative Disorders.

Lorne Schweitzer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.